947691-81-8 Usage
General Description
6-Bromobenzo[d]isothiazole-3-carboxamide is a chemical compound with the molecular formula C9H5BrN2OS. It is a heterocyclic compound that contains a benzene ring fused with an isothiazole ring and a carboxamide group. 6-Bromobenzo[d]isothiazole-3-carboxamide has potential applications in the field of medicinal chemistry due to its interesting structure and potential biological activities. It is used in the synthesis of various pharmaceuticals and biologically active compounds. Additionally, research on 6-Bromobenzo[d]isothiazole-3-carboxamide is ongoing to explore its potential as a drug candidate for various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 947691-81-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,7,6,9 and 1 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 947691-81:
(8*9)+(7*4)+(6*7)+(5*6)+(4*9)+(3*1)+(2*8)+(1*1)=228
228 % 10 = 8
So 947691-81-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrN2OS/c9-4-1-2-5-6(3-4)13-11-7(5)8(10)12/h1-3H,(H2,10,12)
947691-81-8Relevant articles and documents
5H-CYCLOPENTA[D]PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS
-
Page/Page column 80-81, (2009/09/04)
Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. Formula (I).
CINNOLINE AND QUINAZOLINE DERIVATES AS PHOSPHODIESTERASE 10 INHIBITORS
-
Page/Page column 78, (2010/11/28)
The present invention is directed to cinnoline and quinazoline compounds of formula (I) that are PDE10 inhibitors, pharmaceutical compounds containing the same and processes for preparing the same. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme such as obesity, non-insulin dependent diabetes, schizophrenia or bipolar disorder, obsessive-compulsive disorder, and the like.
